Refining small intestinal bacterial overgrowth diagnosis by means of carbohydrate specificity: a proof-of-concept study.

about

Refining small intestinal bacterial overgrowth diagnosis by means of carbohydrate specificity: a proof-of-concept study.

Item

http://www.wikidata.org/entity/Q36793813

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Refining small intestinal bact ...... ity: a proof-of-concept study.

@ast

Refining small intestinal bact ...... ity: a proof-of-concept study.

@en

type

Item

label

Refining small intestinal bact ...... ity: a proof-of-concept study.

@ast

Refining small intestinal bact ...... ity: a proof-of-concept study.

@en

prefLabel

Refining small intestinal bact ...... ity: a proof-of-concept study.

@ast

Refining small intestinal bact ...... ity: a proof-of-concept study.

@en

P1476

Refining small intestinal bact ...... ity: a proof-of-concept study.

@en

P2093

Dietmar Enko

http://www.w3.org/2001/XMLSchema#string

Gabriele Halwachs-Baumann

http://www.w3.org/2001/XMLSchema#string

Gernot Kriegshäuser

http://www.w3.org/2001/XMLSchema#string

Harald Mangge

http://www.w3.org/2001/XMLSchema#string

Robert Stolba

http://www.w3.org/2001/XMLSchema#string

P2860

Small intestinal bacterial overgrowth syndrome

Use and abuse of hydrogen breath tests

Profile of rifaximin and its potential in the treatment of irritable bowel syndrome

The importance of methane breath testing: a review

Understanding interobserver agreement: the kappa statistic

Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance.

Lactose malabsorption testing in daily clinical practice: a critical retrospective analysis and comparison of the hydrogen/methane breath test and genetic test (c/t-13910 polymorphism) results.

Unclear abdominal discomfort: pivotal role of carbohydrate malabsorption.

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials.

The concept of small intestinal bacterial overgrowth in relation to functional gastrointestinal disorders.

P304

265-272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1756283X15621231

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27134657

http://www.w3.org/2001/XMLSchema#string

P921

small intestinal bacterial overgrowth

P932

4830096

http://www.w3.org/2001/XMLSchema#string